Baylor College of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Baylor College of Medicine sits in the top decile of US sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count).
Baylor College of Medicine: 616 sponsored US clinical trials, 93 recruiting.
Baylor College of Medicine sponsors 616 registered US clinical trials on ClinicalTrials.gov, 93 of them currently recruiting, and 376 completed. 59 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Non-Hodgkin Lymphoma, with 7 trials.
Top-decile sponsor footprint
Baylor College of Medicine ranks in the top decile of sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
376 of 452 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
616 total, page 6 of 13
Study of Arginine and Nitric Oxide in Patients With Diabetes
NCT03566524
Coaching and Education for Diabetes Distress
NCT03617146
Nasogastric Decompression Following Pancreaticoduodenectomy
NCT06413888
N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy
NCT03499249
Aromatase Inhibitors and Weight Loss in Severely Obese Men With Hypogonadism
NCT03490513
Comparative Effectiveness of Two Acellular Matrices (Dermacell vs. Integra) for Management of Deep Diabetic Foot Ulcers
NCT03476876
Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection
NCT03172975
Cardiac Biomarkers in Patients With Single Ventricle Physiology
NCT03678909
Tranexamic Acid Per Inhalation for Treatment of Pulmonary Hemorrhage in Pediatric Patients
NCT03676023
Effect of Exercise on Genes That Control Muscle Function
NCT03414385
TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer
NCT03192462
Technology to Improve the Health of Resource-poor Hispanics With Diabetes
NCT03394456
Entolimod, an Adjuvant for Vaccine Augmentation
NCT03063736
Chronic Liver Disease in Urea Cycle Disorders
NCT03721367
Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta
NCT03064074
Lifestyle Intervention to Improve Bone Quality
NCT03329963
Effect of Monochromatic Light on Incidence of Emergence Delirium in Children
NCT03285243
Development and Validation of an Automated Measurement of Child Screen Media Use: FLASH
NCT03382951
Review of Diagnostic Yield of MRI Brain Results in Children Under Age 3 Years
NCT03561168
TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer
NCT03093350
Nitric Oxide Supplementation on Neurocognitive Functions in Patients With ASLD
NCT03064048
Online Videos and New Feeding Content to Enhance a Current EFNEP Program
NCT03170700
Long-term Lifestyle Change and Testosterone Replacement
NCT03256292
Strengths-Based Behavioral mHealth App for Parents of Adolescents With Type 1 Diabetes-Pilot Study
NCT02877680
Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain
NCT02744430
EO2 Oxygen Delivery To Study Success Rate of Surgically Closed Wounds
NCT03960463
Primary Versus Delayed Surgical Therapy for Pediatric Spontaneous Pneumothorax
NCT02449980
Micro-mobile Foot Compression and Diabetic Foot
NCT03135535
Fetal Hemoglobin Induction Treatment Metformin
NCT02981329
Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma
NCT02949700
Gravity Assisted Technique for Esophageal Endoscopic Submucosal Dissection (ESD)
NCT04547881
Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer
NCT02885974
Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants
NCT02943746
Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in Schizophrenia
NCT02975973
Overcoming Obstacles in Epigenetic Analysis of Human Twins
NCT04279704
Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPM
NCT02838745
Prediction of Brain Injury in Premature Infants
NCT02814383
Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)
NCT02933450
Efficacy of Audio Recorded Guided Imagery vs Deep Breathing Exercises on Functional Gastrointestinal Pain Disorders
NCT03100487
Dextrose Gel Does Not Prevent Neonatal Hypoglycemia
NCT02523222
Effect of Caudal and Penile Block on Hypospadias Repair Complications
NCT02851290
Transforming Care and Payment Priorities for Vulnerable Families
NCT03416712
Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)
NCT02959853
High-Risk Neuroblastoma Chemotherapy Without G-CSF
NCT02786719
MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma
NCT02592551
Using Game-based Exercise to Improve Balance in Cancer Patients
NCT02773329
Non-Invasive Direct Current Stimulation for Cognition in Schizophrenia
NCT02739347
Effects of Diet Interventions on Monocytes in Metabolic Syndrome
NCT03591588
Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
NCT02737202
Hummus for Health: Dietary Quality and Health Outcomes in Toddlers
NCT02696278
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 173 |
| Phase 2 | 59 |
| Phase 3 | 13 |
| Phase 4 | 46 |
Therapeutic Areas
What is open in the Baylor College of Medicine pipeline
93 recruiting of 616 indexed (15% open); 376 completed (61%).
Phase mix: 59 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Non-Hodgkin Lymphoma (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Baylor College of Medicine: open-pipeline peers nationwide
Peers matched on 616 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 616 trials (± recruiting share)
- University of Southern California · 617 trials · 16% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Rochester · 636 trials · 15% recruiting
- Janssen Research & Development · 593 trials · 11% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Stanford University · 15% recruiting · 1,744 trials
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- 59th Medical Wing · 15% recruiting · 20 trials
Related
What to do with this Baylor College of Medicine page
616 registered trials is a research-attention snapshot, not an endorsement of Baylor College of Medicine or any single study.
- 93 of Baylor College of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Non-Hodgkin Lymphoma is the condition Baylor College of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Non-Hodgkin Lymphoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Baylor College of Medicine pipeline card: 616 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.